Evidence map›Paper›PMID 18955500›Full record

ArticleMolecular and cellular biology2009

Death receptor-induced activation of the Chk2- and histone H2AX-associated DNA damage response pathways.

Stéphanie Solier, Olivier Sordet, Kurt W Kohn, Yves Pommier

Abstract read
In one paragraph

Article in Molecular and cellular biology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 106 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Histone Phosphorylation in DNA Damage Response.International journal of molecular sciences · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Mutagenic Consequences of Sublethal Cell Death Signaling.International journal of molecular sciences · 2021
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Stéphanie SolierLaboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland 20892-4255, USA.
Olivier Sordet
Kurt W Kohn
Yves Pommier
Center for Cancer Research · USNational Cancer Institute · US

Funding

DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer DrugsZIABC006150 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI POMMIER, YVES · 2009 to 2025
$23.0M
Investigating Regulatory Networks that Control Cell Proliferation and ApoptosisZIABC006192 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI KOHN, KURT · 2009 to 2014
$3.8M
PROTEIN-ASSOCIATED DNA BREAKS AS INDICATOR OF TOPOISOMERASE INHIBITIONZ01BC006150 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI POMMIER, YVES · 1996 to 2008
$1.5M
Molecular regulatory network controling cell proliferatiZ01BC006192 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI KOHN, KURT · 1996 to 2008
$969k
Intramural NIH HHS
6 · The paper itself

Abstract

TRAIL is an endogenous death receptor ligand also used therapeutically because of its selective proapoptotic activity in cancer cells. In the present study, we examined chromatin alterations induced by TRAIL and show that TRAIL induces a rapid activation of DNA damage response (DDR) pathways with histone H2AX, Chk2, ATM, and DNA-PK phosphorylations. Within 1 h of TRAIL exposure, immunofluorescence confocal microscopy revealed gamma-H2AX peripheral nuclear staining (gamma-H2AX ring) colocalizing with phosphorylated/activated Chk2, ATM, and DNA-PK inside heterochromatin regions. The marginal distribution of DDR proteins in early apoptotic cells is remarkably different from the focal staining seen after DNA damage. TRAIL-induced DDR was suppressed upon caspase inhibition or Bax inactivation, demonstrating that the DDR activated by TRAIL is downstream from the mitochondrial death pathway. H2AX phosphorylation was dependent on DNA-PK, while Chk2 phosphorylation was dependent on both ATM and DNA-PK. Downregulation of Chk2 decreased TRAIL-induced cell detachment; delayed the activation of caspases 2, 3, 8, and 9; and reduced TRAIL-induced cell killing. Together, our findings suggest that nuclear activation of Chk2 by TRAIL acts as a positive feedback loop involving the mitochondrion-dependent activation of caspases, independently of p53.

Indexed as

DNA DamageApoptosisAtaxia Telangiectasia Mutated Proteinsbcl-2-Associated X ProteinCaspasesCell CycleCell Cycle ProteinsCell Line, TumorCell NucleusCheckpoint Kinase 2DNA-Activated Protein KinaseDNA-Binding ProteinsEnzyme ActivationHistonesHumansModels, BiologicalAtaxia Telangiectasia Mutated ProteinsATM protein, humanbcl-2-Associated X ProteinCaspasesCell Cycle ProteinsCheckpoint Kinase 2CHEK2 protein, humanDNA-Activated Protein KinaseDNA-Binding ProteinsH2AX protein, humanHistonesNuclear ProteinsPRKDC protein, humanProtein Serine-Threonine KinasesReceptors, Death DomainTNF-Related Apoptosis-Inducing LigandTumor Suppressor Proteins

Identifiers

PMID18955500
PMCPMC2612481
OpenAlexW2132829295

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.